Drug Information

Drug General Information
Drug ID
D04XGX
Former ID
DNC009121
Drug Name
2-(2-Methoxybenzyl)-3H-benzo[f]chromen-3-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530009]
Formula
C21H16O3
Canonical SMILES
COC1=CC=CC=C1CC2=CC3=C(C=CC4=CC=CC=C43)OC2=O
InChI
1S/C21H16O3/c1-23-19-9-5-3-7-15(19)12-16-13-18-17-8-4-2-6-14(17)10-11-20(18)24-21(16)22/h2-11,13H,12H2,1H3
InChIKey
VCXYTPBLXWPGOC-UHFFFAOYSA-N
PubChem Compound ID
44592011
Target and Pathway
Target(s) Cannabinoid receptor 2 Target Info Inhibitor [530009]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 530009Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.
Ref 530009Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.